top of page

The Escalating US Policy Environment. Payer Views on Current Drug Pricing Proposals.

Writer's picture: Ulrich Neumann, MBA MSc MAUlrich Neumann, MBA MSc MA
In recent years, health policy pushes have seen an increasing focus on drug costs. Proposals have embraced concepts like price referencing, transparency requirements, and drug importation. In this report, I examine congressional legislation and commercial payer positions on these approaches. The data reveal little opposition to policies such as international reference pricing or drug importation.
 

Neumann U. (2020). The Escalating US Policy Environment. Payer Views on Current Drug Pricing Proposals. Certara.






Commenti


Vocal.

Sign up today and receive
fresh perspectives in your inbox.
Questions or suggestions?
Send a direct message below.

Success! Message received.

  • White LinkedIn Icon
  • White Facebook Icon
  • White Twitter Icon
  • White Google+ Icon
bottom of page